Pro Share Advisors LLC Fulcrum Therapeutics, Inc. Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,475 shares of FULC stock, worth $55,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,475
Previous 15,410
13.4%
Holding current value
$55,046
Previous $55,000
49.09%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding FULC
# of Institutions
130Shares Held
51.6MCall Options Held
1.04MPut Options Held
32.6K-
Ra Capital Management, L.P. Boston, MA10.2MShares$32.2 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$16.5 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$15.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$15.1 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$10.5 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $164M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...